Genetic Susceptibility to Fungal Infections in Humans

Michail S Lionakis1

  • 1Clinical Mycology Unit, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Insights

Genetic defects in immune function can lead to severe fungal infections like chronic mucocutaneous candidiasis (CMC) and invasive fungal infections (IFIs) in otherwise healthy individuals. This review explores recent findings on these genetic and immunologic factors.

Area of Science:

  • Immunology
  • Genetics
  • Mycology

Background:

  • Fungal infections typically occur in immunocompromised individuals (e.g., HIV, iatrogenic immunosuppression).
  • In healthy hosts, fungi usually cause mild, self-limiting mucocutaneous infections.
  • Persistent or invasive fungal infections in healthy individuals suggest underlying immune dysfunction.

Purpose of the Study:

  • To review recent advancements in understanding genetic and immunologic factors influencing fungal infection risk.
  • To critically discuss the role of innate and adaptive immune dysfunction in chronic mucocutaneous candidiasis (CMC) and invasive fungal infections (IFIs).

Main Methods:

  • Literature review of recent developments in genetics and immunology related to fungal infections.
  • Critical analysis of studies investigating genetic defects and immune dysfunction.

Main Results:

  • Identified genetic defects as a key cause of susceptibility to fungal infections in non-immunocompromised hosts.
  • Highlighted the link between specific immune dysfunctions and the development of CMC and IFIs.
  • Discussed recent findings on the interplay of genetic and immunologic factors.

Conclusions:

  • Genetic defects leading to innate or adaptive immune dysfunction are critical in the pathogenesis of CMC and IFIs in "normal" hosts.
  • Further research into these genetic and immunologic factors is essential for understanding and managing fungal infections.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...